Hypertrophy and hyperplasia.- Development and regression of right heart ventricular hypertrophy: Biochemical and morphological aspects.- Myocardial structure and left ventricular function in hypertrophic and dilative cardiomyopathy and aortic valve disease.- Evidence for muscle fiber hyperplasia in the septum of patients with hypertrophic obstructive cardiomyopathy. Quantitative examination of endomyocardial biopsies and myectomy specimens.- Evidence of myocyte hyperplasia in hypertrophic cardiomyopathy and other disorders with myocardial hypertrophy?.- Variability and reproducibility of morphologic findings in endomyocardial biopsies of patients with hypertrophic obstructive cardiomyopathy.- Myocardial biopsy in patients with hypertrophic cardiomyopathy: Correlations between morphologic and clinical parameters and development of myocardial hypertrophy under medical therapy.- Radionuclide ventriculography, Cardiac computed tomography.- Radionuclide ventriculography: acute and chronic response to verapamil in patients with hypertrophic cardiomyopathy.- Effects of therapeutic interventions on minimal cardiac transit times and volume parameters in hypertrophic cardiomyopathy.- Diagnosis of hypertrophic cardiomyopathies by non-ECG-gated cardiac computed tomography.- Systolic and diastolic function.- Is regional wall stress a stimulus for myocardial hypertrophy in hypertrophic cardiomyopathy?.- Evidence for true obstruction to left ventricular outflow in obstructive hypertrophic cardiomyopathy (muscular or hypertrophic subaortic stenosis).- Dynamic obstruction to left ventricular outflow: The case for its existence in hypertrophic cardiomyopathy.- Diastolic filling properties in different forms of left ventricular hypertrophy, assessed by 2-D echocardiography.- Influence ofverapamil on diastolic left ventricular function in myocardial hypertrophy of different origin.- Systolic anterior movement of the mitral valve and the Venturi effect: an in vitro study.- Myocardial ischemia.- Morphologic evidence for “small vessel disease” in patients with hypertrophic cardiomyopathy.- Myocardial ischemia in hypertrophic cardiomyopathy.- Medical and surgical therapy.- Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.- Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: Results of a multicenter study.- Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.- Programmed electrical stimulation in patients with hypertrophic cardiomyopathy.- 10-year results and survival of patients with hypertrophic cardiomyopathy treated with calcium antagonists.- Techniques and complications of transaortic subvalvular myectomy in patients with hypertrophic obstructive cardiomyopathy.- Experimental and clinical findings in other forms of cardiomyopathy.- Capillary density and oxygen supply in human dilated cardiomyopathy.- Long-term observations in mild forms of cardiomyopathy.- Comparison of verapamil and bepridil in the therapy of familiar cardiomyopathy of the Syrian hamster.- Calcium antagonist treatment in mild forms of cardiomyopathy.
